Acro Biomedical (ACBM) Return on Capital Employed (2017 - 2025)
Acro Biomedical (ACBM) recorded quarterly Return on Capital Employed of 39.31% in Q4 2025, up 35.91% quarter-over-quarter from 28.92% in Q3 2025, and up 3626.0% on a YoY basis from 1.05% in Q4 2024.
Acro Biomedical (ACBM) Return on Capital Employed (2017 - 2025) Analysis & Trends
Acro Biomedical's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 39.31% for Q4 2025.
- In Q4 2025, Return on Capital Employed rose 3626.0% year-over-year to 39.31%; the TTM figure through Dec 2025 stood at 39.31% (up 3626.0% YoY), while the FY2025 annual figure was 40.74%, up 3759.0% from the prior year.
- Return on Capital Employed was 39.31% for Q4 2025 at Acro Biomedical, up from 28.92% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 740.33% in Q4 2023 to a low of 62212.3% in Q3 2023.
- Historically, Return on Capital Employed has averaged 4352.18% across 5 years, with a median of 1077.9% in 2024.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed tumbled 5912579 bps in 2023, then soared 5970295 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 1274.19% in 2021, then sank by 168 bps to 3416.88% in 2022, then soared by 122 bps to 740.33% in 2023, then sank by 100 bps to 3.05% in 2024, then jumped by 1191 bps to 39.31% in 2025.
- The last three Return on Capital Employed figures came in at 39.31% (Q4 2025), 28.92% (Q3 2025), and 3.63% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -0.25% |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -0.18% |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -0.36% |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -1.56% |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -0.22% |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -0.25% |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -1.55% |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -0.36% |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -1.28% |
| 10 | Acro Biomedical | - | - | - | 39.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.31% |
| Sep 30, 2025 | 28.92% |
| Jun 30, 2025 | 3.63% |
| Mar 31, 2025 | 2.50% |
| Dec 31, 2024 | 3.05% |
| Sep 30, 2024 | -2,509.35% |
| Jun 30, 2024 | -2,049.79% |
| Mar 31, 2024 | -881.61% |
| Dec 31, 2023 | 740.33% |
| Sep 30, 2023 | -62,212.30% |
| Jun 30, 2023 | -3,799.53% |
| Mar 31, 2023 | -3,741.32% |
| Dec 31, 2022 | -3,416.88% |
| Sep 30, 2022 | -3,086.51% |
| Jun 30, 2022 | -2,391.60% |
| Mar 31, 2022 | -1,703.65% |
| Dec 31, 2021 | -1,274.19% |
| Sep 30, 2021 | -648.32% |
| Jun 30, 2021 | -129.65% |
| Mar 31, 2021 | -16.67% |